These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27034145)

  • 81. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction.
    Naito H; Kuzumaki N; Uchino J; Kobayashi R; Shikano T; Ishikawa Y; Matsumoto S
    Eur J Cancer; 1991; 27(6):762-5. PubMed ID: 1676900
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase.
    Jikai J; Shamis M; Huebener N; Schroeder U; Wrasidlo W; Wenkel J; Lange B; Gaedicke G; Shabat D; Lode HN
    Cancer Lett; 2003 Jul; 197(1-2):219-24. PubMed ID: 12880985
    [TBL] [Abstract][Full Text] [Related]  

  • 83. IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome.
    Morandi F; Croce M; Cangemi G; Barco S; Rigo V; Carlini B; Amoroso L; Pistoia V; Ferrini S; Corrias MV
    J Immunol Res; 2015; 2015():718975. PubMed ID: 25961062
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Tyrosine hydroxylase and choline acetyltransferase activity in human neuroblastoma. Correlations with clinical features.
    Yokomori K; Tsuchida Y; Saito S
    Cancer; 1983 Jul; 52(2):263-72. PubMed ID: 6134577
    [TBL] [Abstract][Full Text] [Related]  

  • 85. New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma.
    Parareda A; Villaescusa JC; Sanchez de Toledo J; Gallego S
    Neurosci Lett; 2003 Jan; 336(1):29-32. PubMed ID: 12493595
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Expression of the periostin mRNA level in neuroblastoma.
    Sasaki H; Sato Y; Kondo S; Fukai I; Kiriyama M; Yamakawa Y; Fuji Y
    J Pediatr Surg; 2002 Sep; 37(9):1293-7. PubMed ID: 12194119
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Correlation between tyrosine hydroxylase immunoreactive cells in tumors and urinary catecholamine output in neuroblastoma patients.
    Ceccamea A; Carlei F; Dominici C; Castello MA; Lomanto D; Cappelli CA; Lezoche E
    Tumori; 1986 Oct; 72(5):451-7. PubMed ID: 2879374
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Shed tumor gangliosides and progression of human neuroblastoma.
    Valentino L; Moss T; Olson E; Wang HJ; Elashoff R; Ladisch S
    Blood; 1990 Apr; 75(7):1564-7. PubMed ID: 2317562
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.
    Kim PY; Tan O; Diakiw SM; Carter D; Sekerye EO; Wasinger VC; Liu T; Kavallaris M; Norris MD; Haber M; Chesler L; Dolnikov A; Trahair TN; Cheung NK; Marshall GM; Cheung BB
    J Proteomics; 2014 Jan; 96():1-12. PubMed ID: 24200836
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Plasma midkine level is a prognostic factor for human neuroblastoma.
    Ikematsu S; Nakagawara A; Nakamura Y; Ohira M; Shinjo M; Kishida S; Kadomatsu K
    Cancer Sci; 2008 Oct; 99(10):2070-4. PubMed ID: 19016768
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival.
    Meleshko A; Kushniarova L; Shinkevich V; Mikhaleuskaya T; Valochnik A; Proleskovskaya I
    Cancer Diagn Progn; 2023; 3(6):695-705. PubMed ID: 37927813
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.
    Favrot MC; Ambros P; Schilling F; Frappaz D; Combaret V; Berthold F; Dominici C; Erttmann R; Esteve J; Jenkner A; Kerbl R; Mann J; Mathieu P; Parker L; Powell J; Philip T
    Ann Oncol; 1996 Aug; 7(6):607-11. PubMed ID: 8879375
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Serum tyrosine hydroxylase activity is increased in melanoma patients. An ROC curve analysis.
    Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
    Cancer Lett; 1998 Jul; 129(2):151-5. PubMed ID: 9719456
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Plasma neurotensin: lack of a differentiation and tumor marker in children with neuroblastoma.
    Becker K; Berthold F
    Pediatr Hematol Oncol; 1992; 9(3):269-72. PubMed ID: 1525006
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Predicting the future of advanced prostate cancer.
    Sørensen KD
    Lancet Oncol; 2012 Nov; 13(11):1067-8. PubMed ID: 23059048
    [No Abstract]   [Full Text] [Related]  

  • 96. The administration of the nerve growth factor to children with widespread neuroblastoma.
    Kumar S; Steward JK; Waghe M; Pearson D; Edwards DC; Fenton EL; Griffith AH
    J Pediatr Surg; 1970 Feb; 5(1):18-22. PubMed ID: 4314039
    [No Abstract]   [Full Text] [Related]  

  • 97. Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma.
    Seo ES; Lee EJ; Lee B; Shin M; Cho YS; Hyun JK; Cho HW; Ju HY; Yoo KH; Koo HH; Lee JW; Sung KW
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32847064
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Plasma acute phase proteins and metalloproteins in children with neuroblastoma at diagnosis.
    Lipińska L; Izbicki T; Laskowska-Klita T; Perek D
    Ann N Y Acad Sci; 1995 Jul; 762():443-5. PubMed ID: 7545377
    [No Abstract]   [Full Text] [Related]  

  • 99. Rethinking high-risk neuroblastoma treatment.
    Cohn SL; Pearson ADJ
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29730. PubMed ID: 35441788
    [No Abstract]   [Full Text] [Related]  

  • 100. Mechanism for nuclear disassembly of the Ar+Th and Pb+Au systems at intermediate energies.
    Barz HW; Bondorf JP; Dasso CH; Donangelo R; Pollarolo G; Schulz H; Sneppen K
    Phys Rev C Nucl Phys; 1992 Jul; 46(1):R42-R44. PubMed ID: 9968134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.